Literature DB >> 17390182

Trends and predictors for vagotomy when performing oversew of acute bleeding duodenal ulcer in the United States.

Brian C Reuben1, Greg Stoddard, Robert Glasgow, Leigh A Neumayer.   

Abstract

BACKGROUND: In the era of Helicobacter pylori treatment, the role of vagotomy in bleeding duodenal ulcers is debatable. National outcomes were evaluated to determine the current surgical treatment and use of vagotomy for bleeding duodenal ulcers.
METHODS: Data from the Nationwide Inpatient Sample (NIS) were used from years 1999 to 2003. Patients were selected using diagnostic codes for acute duodenal ulcer bleed and procedure codes for simple oversew of a bleeding ulcer and vagotomy. Data were analyzed using multiple linear and logistic regression.
RESULTS: Between 1999 and 2003, 100,931 patients with an acute bleeding duodenal ulcer were identified. Over time, there was a decrease in the number of acute bleeding ulcers (p = 0.027) and a decrease in the number of vagotomies (p = 0.027). A high co-morbidity index [odds ratio (OR), 0.60, p = 0.017], operation in the Midwest (OR 0.50, p < 0.001) and operation in the West (OR 0.68, p = 0.034) were predictive of no vagotomy during surgery for a bleeding duodenal ulcer.
CONCLUSIONS: A vagotomy is not commonly performed during surgical treatment of an acute bleeding duodenal ulcer. This variation in practice was not fully explained by patient characteristics. We must seek new evidence to determine the safety of combined medical and surgical management of this clinical problem.

Entities:  

Mesh:

Year:  2007        PMID: 17390182     DOI: 10.1007/s11605-006-0020-z

Source DB:  PubMed          Journal:  J Gastrointest Surg        ISSN: 1091-255X            Impact factor:   3.452


  25 in total

Review 1.  Proximal gastric vagotomy: does it have a place in the future management of peptic ulcer?

Authors:  A G Johnson
Journal:  World J Surg       Date:  2000-03       Impact factor: 3.352

2.  Randomized, double-blind comparison of immediate-release omeprazole oral suspension versus intravenous cimetidine for the prevention of upper gastrointestinal bleeding in critically ill patients.

Authors:  Steven A Conrad; Andrea Gabrielli; Benjamin Margolis; Andrew Quartin; J Steven Hata; William O Frank; Robert G Bagin; James A Rock; Bonnie Hepburn; Loren Laine
Journal:  Crit Care Med       Date:  2005-04       Impact factor: 7.598

3.  From Billroth to PCV: a century of gastric surgery.

Authors:  P H Weil; R Buchberger
Journal:  World J Surg       Date:  1999-07       Impact factor: 3.352

4.  A new method of classifying prognostic comorbidity in longitudinal studies: development and validation.

Authors:  M E Charlson; P Pompei; K L Ales; C R MacKenzie
Journal:  J Chronic Dis       Date:  1987

5.  A prospective randomized comparative trial showing that omeprazole prevents rebleeding in patients with bleeding peptic ulcer after successful endoscopic therapy.

Authors:  H J Lin; W C Lo; F Y Lee; C L Perng; G Y Tseng
Journal:  Arch Intern Med       Date:  1998-01-12

6.  Successful eradication of Helicobacter pylori prevents relapse of peptic ulcer disease.

Authors:  T Tomita; Y Fukuda; K Tamura; J Tanaka; N Hida; T Kosaka; K Hori; T Sakagami; M Satomi; T Shimoyama
Journal:  Aliment Pharmacol Ther       Date:  2002-04       Impact factor: 8.171

7.  Endoscopic hemostasis. An effective therapy for bleeding peptic ulcers.

Authors:  H S Sacks; T C Chalmers; A L Blum; J Berrier; D Pagano
Journal:  JAMA       Date:  1990-07-25       Impact factor: 56.272

8.  Laparoscopic versus open appendectomy: outcomes comparison based on a large administrative database.

Authors:  Ulrich Guller; Sheleika Hervey; Harriett Purves; Lawrence H Muhlbaier; Eric D Peterson; Steve Eubanks; Ricardo Pietrobon
Journal:  Ann Surg       Date:  2004-01       Impact factor: 12.969

9.  Emerging trends in peptic ulcer disease and damage control surgery in the H. pylori era.

Authors:  Brian R Smith; Bruce E Stabile
Journal:  Am Surg       Date:  2005-09       Impact factor: 0.688

10.  [Surgical treatment of severe ulcerous hemorrhages: predictive factors of operative mortality].

Authors:  B Dousset; B Suc; M J Boudet; D Cherqui; N Rotman; M Julien; P L Fagniez
Journal:  Gastroenterol Clin Biol       Date:  1995-03
View more
  1 in total

1.  Therapy with omeprazole modulates regulatory T cell/T helper 17 immune response in children with duodenal ulcers.

Authors:  Chuan-Ying Li; Cheng Wu
Journal:  Inflammopharmacology       Date:  2017-07-22       Impact factor: 4.473

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.